FDA pushes to remove pregnancy drug, company pushes back

Oct 16, 2022, 6:31 PM | Updated: Oct 17, 2022, 6:35 am
This image provided by Covis Pharma shows packaging for the company's Makena medication. Covis, the...

This image provided by Covis Pharma shows packaging for the company's Makena medication. Covis, the maker of the only U.S. drug intended to prevent premature births will make a last-ditch effort to keep its medication on the market in October 2022, even as health regulators revisit mounting evidence that it doesn't work. (Covis Pharma via AP)

(Covis Pharma via AP)

WASHINGTON (AP) — The maker of the only U.S. drug intended to prevent premature births is making a last-ditch effort this week to keep its medication on the market, even as health regulators insist that it doesn’t work.

A Food and Drug Administration meeting that opened Monday comes more than two years after the agency declared the drug ineffective and called for its removal. Drugmaker Covis Pharma has challenged the agency’s conclusion, setting up the highly unusual three-day public hearing.

The meeting underscores the limits of FDA’s authority and the long, onerous process to remove a drug on the rare occasion when a company won’t do so voluntarily at the agency’s request.

The hearing will resemble a courtroom trial, with FDA staff and company scientists presenting arguments for and against the drug Makena, followed by a vote Wednesday by a panel of outside experts. FDA leaders will ultimately make the final decision whether to order a withdrawal.

About 10% of U.S. births come too early — before 37 weeks, raising the risk of serious health problems and even death in infants. Complicating the Makena debate is support from the leading U.S. obstetrics group to keep the decade-old drug available while more research is done.

“The need for an effective treatment for preterm birth is great,” the American College of Obstetricians and Gynecologists says. “Makena and its associated generics represent the only treatment currently available to obstetrician-gynecologists to help prevent this condition.”

But the FDA says existing data shows weekly injections of the drug don’t help prevent a repeat preterm birth.

“Based on the evidence shown today, Makena is not shown to be effective,” said FDA’s drug chief, Dr. Patrizia Cavazzoni, in opening remarks Monday. “Its benefit and risk profile is unfavorable and it should be withdrawn from the market.”

The dispute is likely to increase scrutiny of the agency’s so-called accelerated approval program, which allows drugs like Makena to launch based on promising early results while additional, usually larger, studies are conducted.

“Makena is being used as an example of the many different criticisms of this program,” said Rachel Sachs, a food and drug law specialist at Washington University of St. Louis. “That may not be fair to the other drugs, other diseases, other patients groups, but we’re forced to respond to the situation it presents.”

At its best, the accelerated approval program is credited with speeding the availability of breakthrough therapies for HIV and cancer. But in the last decade, the FDA has been increasingly criticized for failing to follow up on expedited drugs with incomplete or unconvincing confirmatory data, including a large number of expensive cancer medications on the market.

In recent years, the FDA’s cancer division has begun prodding companies to stop selling their drugs for uses granted under these so-called “dangling approvals.”

The FDA approved Makena in 2011 based on a small study suggesting it reduced rates of premature birth in women with a history of early deliveries. Makena consists of a synthetic version of the hormone progesterone, which helps the uterus grow and maintain a pregnancy. Women can start the shots after 16 weeks of pregnancy.

Accelerated approval was granted on the condition that Makena’s original developer, Hologic, conduct a follow-up study confirming the drug resulted in lower rates of disability and death among newborns.

But results from an international study of 1,700 women released in 2019 showed the drug neither reduced premature births — as originally thought — nor resulted in healthier outcomes for babies, while increasing the risk of blood clots, depression and other side effects in mothers.

In briefing documents released this month, the FDA said leaving Makena on the market “incurs false hopes, the risks associated with treatment, and other burdens” like excess medical spending. According to a recent federal report, the U.S. has spent $700 million on Makena since 2018 through various government programs, like Medicaid and Veterans Affairs.

The FDA opinion also applies to several generic versions of the shot.

Drugmaker Covis argues that Makena is effective and that flaws in the 2019 study obscured its benefit. The Luxembourg-based company points out that Black women are at higher risk for preterm birth, but made up just 7% of women in the international study, compared with 59% in the original U.S. study used for approval. It wants time to do another study in higher risk patients, particularly Black Americans.

A patient group set up with funding by Covis, the Preterm Birth Prevention Alliance, has made similar arguments in letters to the FDA.

“We believe there is no sound public health reason to deprive” patients and physicians of access to Makena, the company said in an emailed statement.

___

Follow Matthew Perrone on Twitter: @AP_FDAwriter

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Associated Press

Railway workers in Austria to strike Monday in pay standoff

BERLIN (AP) — Railway workers in Austria are set to hold a one-day strike on Monday after a failed round of talks in pay negotiations. The Austria Press Agency reported Sunday that both sides said the fifth round of talks on pay for some 50,000 employees of about 65 railway operators, including the main national […]
1 day ago
FILE - In this Aug. 7, 2017 file photo, a Royal Canadian Mounted Police officer informs a migrant c...
Associated Press

Mexican asylum seekers set their sights north — on Canada

MONTREAL (AP) — Pedro Meraz says living in Colima, Mexico, was like living in a war zone, with shootings, burning cars and dismembered bodies being left outside of schools. When his wife Rocio Gonzalez, a 28-year-old lawyer who worked with abused women, began receiving death threats from a cartel and the local authorities ignored her […]
1 day ago
General view of the damaged Antonivsky Bridge in Kherson, Ukraine, Sunday, Nov. 27, 2022. The bridg...
Associated Press

Pockets of shelling across Ukraine as wintry warfare looms

KHERSON, Ukraine (AP) — Shelling by Russian forces struck several areas in eastern and southern Ukraine overnight as utility crews continued a scramble to restore power, water and heating following widespread strikes in recent weeks, officials said Sunday. With persistent snowfall blanketing the capital, Kyiv, Sunday, analysts predicted that wintry weather — bringing with it […]
1 day ago
Monkeys enjoy fruit during monkey feast festival in Lopburi province, Thailand. Sunday, Nov. 27, 20...
Associated Press

Monkeys in central Thailand city mark their day with feast

LOPBURI, Thailand (AP) — A meal fit for monkeys was served on Sunday at the annual Monkey Feast Festival in central Thailand. Amid the morning traffic, rows of monkey statues holding trays were lined up outside the compound of the Ancient Three Pagodas, while volunteers prepared food across the road for real monkeys — the […]
1 day ago
A man shovels mud after heavy rainfall triggered landslides that collapsed buildings and left as ma...
Associated Press

Italian rescuers search for missing in island landslide

MILAN (AP) — Rescuers dug through mud for a second day Sunday in the search for people believed lost in an enormous landslide on the Italian resort island of Ischia. One body was recovered on Saturday and two families with children remained among the 11 missing in the port town of Casamicciola, feared buried under […]
1 day ago
This is a locator map for Pakistan with its capital, Islamabad, and the Kashmir region. (AP Photo)...
Associated Press

Pakistan arrests senator over comments about army chief

ISLAMABAD (AP) — Federal police in Pakistan have arrested a senator for comments critical of top military officers, colleagues from his Tehreek-e-Insaf political party said Sunday. It was the second time he was taken into custody in as many months. Azam Khan Swati, a senior member of the party of former Prime Minister Imran Khan […]
1 day ago

Sponsored Articles

SHIBA WA...

Medicare open enrollment is here and SHIBA can help!

The SHIBA program – part of the Office of the Insurance Commissioner – is ready to help with your Medicare open enrollment decisions.
Lake Washington Windows...

Choosing Best Windows for Your Home

Lake Washington Windows and Doors is a local window dealer offering the exclusive Leak Armor installation.
Anacortes Christmas Tree...

Come one, come all! Food, Drink, and Coastal Christmas – Anacortes has it all!

Come celebrate Anacortes’ 11th annual Bier on the Pier! Bier on the Pier takes place on October 7th and 8th and features local ciders, food trucks and live music - not to mention the beautiful views of the Guemes Channel and backdrop of downtown Anacortes.
Swedish Cyberknife Treatment...

The revolutionary treatment of Swedish CyberKnife provides better quality of life for majority of patients

There are a wide variety of treatments options available for men with prostate cancer. One of the most technologically advanced treatment options in the Pacific Northwest is Stereotactic Body Radiation Therapy using the CyberKnife platform at Swedish Medical Center.
Work at Zum Services...

Seattle Public Schools announces three-year contract with Zum

Seattle Public Schools just announced a three-year contract with a brand-new company to the Pacific Northwest to assist with their student transportation: Zum.
Swedish Cyberknife 900x506...

June is Men’s Health Month: Here’s Why It’s Important To Speak About Your Health

According to the Centers for Disease Control and Prevention, men in the United States, on average, die five years earlier than women.
FDA pushes to remove pregnancy drug, company pushes back